Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
vaccin mot difteri, kikhosta, stelkramp och Haemophilus influenzae typ B |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
vaccin mot Haemophilus influenzae typ B |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
vaccin mot Haemophilus influenzae typ B, difteri, stelkramp och kikhosta, flaska och förfylld spruta |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
vaccin mot Haemophilus influenzae typ B, difteri, stelkramp och kikhosta, förfylld spruta |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
vaccin mot Haemophilus influenzae typ B, difteri, stelkramp och kikhosta, injektionsflaska |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
vaccin mot Haemophilus influenzae typ B, injektion, pulver för rekonstituering och spädningsvätska |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
vaccin mot difteri, stelkramp, kikhosta, polio och Haemophilus influenzae typ B |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
3 |
vaccin mot difteri, stelkramp, kikhosta, polio och Haemophilus influenzae typ B, injektionsflaska 0,5 ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
konjugerat vaccin med polysackarid från Haemophilus influenzae typ B (difteri-toxoidkonjugat) |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
konjugerat vaccin med oligosackarid från Haemophilus influenzae typ B (difteri-CRM197-proteinkonjugat) |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 7.5ml/5ml (product) |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
Haemophilus B-polysackarid 10 mikrogram och tetanustoxoid 24 mikrogram |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoid 0.5vial/haemophilus b conjugate injection suspension vial |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of third dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
förgiftning orsakad av vaccin mot Haemophilus influenzae typ B |
Causative agent |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
oavsiktlig förgiftning orsakad av vaccin mot Haemophilus influenzae typ B |
Causative agent |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
avsiktlig förgiftning orsakad av vaccin mot Haemophilus influenzae typ B |
Causative agent |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
förgiftning orsakad av vaccin mot Haemophilus influenzae typ B, med oklar avsikt |
Causative agent |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Adverse reaction to component of vaccine product containing Haemophilus influenzae type b antigen (disorder) |
Causative agent |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Allergy to Haemophilus influenzae type b vaccine |
Causative agent |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
vaccin mot Haemophilus influenzae typ B och meningokocker grupp C |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
vaccin mot Haemophilus influenzae typ B och rekombinant vaccin mot hepatit B-virus |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
vaccin mot Haemophilus influenzae typ B 7,5 mikrogram och rekombinant ytantigenvaccin mot hepatit B 5 mikrogram, injektionsvätska, lösning, flaska 0,5 ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
vaccin mot Haemophilus influenzae typ B och stelkramp |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Haemophilus B-polysackarid 10 mikrogram och tetanustoxoid 30 mikrogram, pulver till injektionsvätska, flaska + spädningsvätska |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, rekombinant hepatit B-ytantigen 10 mikrogram, inaktiverat poliovirus, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
Haemophilus influenzae typ B 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, kikhosta 25 mikrogram, rekombinant hepatit B-ytantigen 10 mikrogram, inaktiverat poliovirus, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
vaccin mot difteri, stelkramp, kikhosta och polio samt rekombinant vaccin mot hepatit B-virus och Haemophilus influenzae typ B |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
3 |
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
vaccin mot difteri, stelkramp och Haemophilus influenzae typ B |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of third dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of third dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Allergy to Haemophilus influenzae type b vaccine |
Causative agent |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
konjugatvaccin i form av kapselpolysackarid mot Haemophilus influenzae typ b (Ross-stammen) (konjugerade meningokockproteiner) och ytanti-genvaccin mot hepatit B |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of second dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
4 |
Administration of first dose of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
4 |
Haemophilus B-polysackarid 10 mikrogram + tetanustoxoid 30 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
|
Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
5 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of first dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
3 |
Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
3 |
vaccin mot Haemophilus influenzae typ B 7,5 mikrogram och rekombinant ytantigenvaccin mot hepatit B 5 mikrogram, injektionsvätska, lösning, flaska 0,5 ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Haemophilus B-polysackarid 10 mikrogram + tetanustoxoid 30 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
vaccination mot difteri, kikhosta, stelkramp, poliomyelit, hepatit B-virus och Haemophilus influenzae typ B |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
3 |
Haemophilus influenzae typ B 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, kikhosta 25 mikrogram, rekombinant hepatit B-ytantigen 10 mikrogram, inaktiverat poliovirus, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure) |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, rekombinant hepatit B-ytantigen 10 mikrogram, inaktiverat poliovirus, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Has active ingredient |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |
Administration of Haemophilus influenzae type b and hepatitis B vaccine |
Direct substance |
False |
vaccin mot Haemophilus influenzae typ B |
Inferred relationship |
Some |
2 |